Immatics (IMTX) Cash from Financing Activities (2019 - 2025)

Immatics' (IMTX) quarterly Cash from Financing Activities came in at $115.9 million in Q4 2025, down 25.91% year-on-year from $156.4 million in Q4 2024, and up 13604.66% quarter-over-quarter from -$858086.4 in Q3 2025.

Immatics (IMTX) Cash from Financing Activities (2019 - 2025) Analysis & Trends

Immatics has disclosed Cash from Financing Activities across 7 years of filings, most recently posting $115.9 million for Q4 2025.

  • Cash from Financing Activities for Q4 2025 came in at $115.9 million, down 25.91% year-over-year; the trailing twelve-month figure through Dec 2025 was $113.4 million (down 67.09% YoY), and the FY2025 annual result was $110.0 million, down 67.8% from the prior year.
  • Cash from Financing Activities came in at $115.9 million for Q4 2025 at Immatics, up from -$858086.4 in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $189.7 million in Q1 2024 to a low of -$1.0 million in Q4 2023.
  • The 5-year median for Cash from Financing Activities is -$639942.7 (2021), against an average of $33.7 million.
  • Across the five-year window, Cash from Financing Activities slumped 482.48% in 2021 and jumped 20511.49% in 2024, its largest moves.
  • Immatics' Cash from Financing Activities stood at -$670367.0 in 2021, then surged by 16154.62% to $107.6 million in 2022, then plunged by 100.97% to -$1.0 million in 2023, then jumped by 15054.62% to $156.4 million in 2024, then retreated by 25.91% to $115.9 million in 2025.
  • The last three Cash from Financing Activities figures came in at $115.9 million (Q4 2025), -$858086.4 (Q3 2025), and -$822934.7 (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 7.00 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -600,000.00
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 53,000.00
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -538.80 Mn
9 Abivax 91.96 Bn 91.96 Bn - 85,464.43
10 Immatics 14.67 Bn 14.67 Bn - 115.88 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 115.88 Mn
Dec 31, 2025 115.88 Mn
Sep 30, 2025 -858,086.44
Sep 30, 2025 -858,086.44
Jun 30, 2025 -822,934.69
Jun 30, 2025 -822,934.69
Mar 31, 2025 -775,238.83
Mar 31, 2025 -775,238.83
Dec 31, 2024 156.40 Mn
Dec 31, 2024 156.40 Mn
Sep 30, 2024 -826,959.29
Sep 30, 2024 -826,959.29
Jun 30, 2024 -609,518.37
Jun 30, 2024 -609,518.37
Mar 31, 2024 189.73 Mn
Mar 31, 2024 189.73 Mn
Dec 31, 2023 -1.05 Mn
Dec 31, 2023 -1.05 Mn
Sep 30, 2023 54.32 Mn
Sep 30, 2023 54.32 Mn